Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TELOVAC: Telomerase Vaccine GV1001 with Gemcitabine and Capecitabine in Pancreatic Cancer
NCT00425360Phase 3Completed
- Sponsor
- Royal Liverpool University Hospital
- Start
- Sep 2006
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tertomotide in pancreatic cancer (PC), sponsored by Royal Liverpool University Hospital. Started Sep 2006; status: completed.
02
Drugs
tertomotide
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00425360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425360.